Scientists developed an optimised expansion and transduction protocol for primary human NK cells primed for manufacturing scaling and clinical evaluation.
[Clinical & Translational Immunology]
Home Newsletters Cell Therapy News Optimisation of a Primary Human CAR-NK Cell Manufacturing Pipeline
